Electra Therapeutics Inc. Common stock (ETRA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Electra Therapeutics Inc. Common stock, updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$8.98
+5.40% today
Market cap
$535M
Overall quality
53/100
Kronos AI 30-day
—
Electra Therapeutics Inc. Common stock (ETRA) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $535M. It trades at $8.98, up 5.40% today. Its overall quality score is 53 out of 100, ranked against the whole US market. 5 analysts' average target of $32.67 implies +263.8% from today's price.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $32.67 |
| Low – high | $30.00 – $36.00 |
| Analysts | 5 |
| Upside to average | +263.8% |
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
| Profitability | 50 |
| Solvency | 65 |
| Growth | 44 |
| Overall | 53 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.